Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04775537

OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Sponsor: Collagen Matrix

View on ClinicalTrials.gov

Summary

The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material

Official title: OssiMend Bioactive Moldable in Posterolateral Instrumented Lumbar Fusion

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2021-01-21

Completion Date

2027-01-30

Last Updated

2025-10-16

Healthy Volunteers

No

Interventions

DEVICE

OssiMend™ Bioactive Moldable

Lumbar Spine fusion with OssiMend™ Bioactive Moldable

Locations (4)

San Diego Neurosurgery

Encinitas, California, United States

Hartford Hospital

Hartford, Connecticut, United States

University Orthopaedic Associates, Division of OrthoNJ

Somerset, New Jersey, United States

McKenzie-willamette Medical Center

Eugene, Oregon, United States